Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Galantamine is a medication with scientific validation for use in the treatment of dementia, specifically mild to moderate Alzheimer's disease. It is an alkaloid originally derived from the bulbs of certain plants, including the snowdrop (Galanthus spp.). Galantamine acts as a reversible, competitive inhibitor of acetylcholinesterase, the enzyme responsible for breaking down acetylcholine in the brain. By inhibiting this enzyme, galantamine increases the concentration of acetylcholine, which is associated with improved cognitive function in Alzheimer's disease patients. Additionally, galantamine is thought to modulate nicotinic acetylcholine receptors, further enhancing cholinergic neurotransmission.

The efficacy and safety of galantamine have been demonstrated in multiple randomized, double-blind, placebo-controlled clinical trials. These studies show modest but statistically significant improvements in cognitive function, activities of daily living, and global clinical assessments compared to placebo. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved galantamine for the symptomatic treatment of Alzheimer's disease. However, it is important to note that while galantamine can help manage symptoms, it does not cure or halt the progression of dementia. The overall effect size is considered moderate, and treatment should be tailored to individual patient needs and tolerability.

More about Galantamine
More about Dementia

Other ingredients used for Dementia

Other health conditions supported by Galantamine

Products containing Galantamine